K

Kyung Nam Pharm Co Ltd
KOSDAQ:053950

Watchlist Manager
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Watchlist
Price: 642 KRW -2.58% Market Closed
Market Cap: 50.2B KRW

Kyung Nam Pharm Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kyung Nam Pharm Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Operating Income
-â‚©662.3m
CAGR 3-Years
58%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Operating Income
â‚©92B
CAGR 3-Years
39%
CAGR 5-Years
25%
CAGR 10-Years
1%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
â‚©147.6B
CAGR 3-Years
178%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©200.9B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
35%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
-â‚©1.8B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Operating Income
â‚©36.4B
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Kyung Nam Pharm Co Ltd
Glance View

Market Cap
50.2B KRW
Industry
Pharmaceuticals

Kyungnam Pharm Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Uiryeong-Gun, Gyeongsangnam-Do. The company went IPO on 2001-11-06. The firm's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The firm provides vitamin products under the brand name LEMONA. The company supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.

Intrinsic Value
898.18 KRW
Undervaluation 29%
Intrinsic Value
Price
K

See Also

What is Kyung Nam Pharm Co Ltd's Operating Income?
Operating Income
-662.3m KRW

Based on the financial report for Jun 30, 2025, Kyung Nam Pharm Co Ltd's Operating Income amounts to -662.3m KRW.

What is Kyung Nam Pharm Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
23%

Over the last year, the Operating Income growth was 87%. The average annual Operating Income growth rates for Kyung Nam Pharm Co Ltd have been 58% over the past three years , 23% over the past five years .

Back to Top